Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT01808313 · COMPLETED

Trial details

NCT number: NCT01808313
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Vascular Disease

Start date: 2012-12-01
Primary completion: 2014-08-15
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.